Tag: Seniors’ health
CDC probes deaths in immunized patients in nursing homes
WASHINGTON — Lagging vaccination rates among nursing home staff are being linked to a national increase in COVID-19 infections and deaths at senior facilities...
Ex-aide launches new salvo against UK’s Johnson over virus
LONDON — A disgruntled former top aide to Prime Minister Boris Johnson says the British leader was dismissive of the threat posed by surging...
First vaccinations given in Haiti since start of pandemic
PORT-AU-PRINCE, Haiti — Health care workers and senior citizens were the first people vaccinated on Friday in Haiti as part of a test run...
Medicare evaluating coverage for $56,000 Alzheimer’s drug
WASHINGTON — Medicare on Monday launched a formal process to decide whether to cover Aduhelm, the new Alzheimer's drug whose $56,000-a-year price tag and...
Bill aims to spend billions to fix nation’s aging dams
BOSTON — Lawmakers in Congress on Friday introduced a bill that would pump tens of billions of dollars into fixing and upgrading the country’s...
FDA head calls for probe into Alzheimer’s drug review
WASHINGTON — The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between some...
FDA trims use of contentious Alzheimer’s drug amid backlash
WASHINGTON — U.S. health regulators on Thursday approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug.
...
Does new Alzheimer’s drug work? Answers may miss 2030 target
WASHINGTON — When a controversial Alzheimer’s drug won U.S. approval, surprise over the decision quickly turned to shock at how long it might take...
Alzheimer’s drug stirs hope for patients, worry for doctors
In the weeks since a new Alzheimer's drug was approved, hopeful patients have bombarded Dr. Alireza Atri with calls and emails about a treatment...
Lilly to seek FDA approval for potential Alzheimer’s drug
INDIANAPOLIS — Eli Lilly said Thursday that it will submit its potential Alzheimer’s treatment to federal regulators later this year.
...